文献速递鼻科咽喉与嗓音

长期鼻内糖皮质激素治疗诱导正常及过敏性鼻炎小鼠嗅觉感觉神经元退变

Chronic intranasal corticosteroid treatment induces degeneration of olfactory sensory neurons in normal and allergic rhinitis mice.
PubMed 文献 · Int Forum Allergy Rhinol · 2023-03-10

该研究在BALB/c小鼠中评估长期鼻内丙酸氟替卡松(FP,0.3 mg/kg)治疗对嗅觉功能及嗅觉感觉神经元(OSN)的影响。正常小鼠经FP治疗8周后嗅觉敏感度下降,伴OSN及投射至嗅球的轴突丢失,主要源于神经元凋亡增加;在卵白蛋白诱导的过敏性鼻炎小鼠中,FP治疗8周减轻嗅觉障碍及嗜酸性炎症,但未能重建OSN数量及轴突投射。结果提示长期鼻内糖皮质激素治疗可导致OSN退变,可能降低其对过敏性鼻炎相关嗅觉丧失的疗效。

要点

  • 正常小鼠鼻内FP治疗8周后嗅觉敏感度下降,伴OSN及轴突丢失。
  • FP治疗8周过敏性鼻炎小鼠嗅觉障碍及嗜酸性炎症减轻,但OSN未重建。
  • 长期鼻内糖皮质激素可能通过增加神经元凋亡导致OSN退变。

核心结论

  • 长期鼻内糖皮质激素治疗可导致OSN退变,可能降低其对过敏性鼻炎相关嗅觉丧失的疗效。

研究设计与样本

  • BALB/c小鼠鼻内给予丙酸氟替卡松(FP,0.3 mg/kg)治疗最长8周。
  • 另用卵白蛋白诱导过敏性鼻炎小鼠模型,鼻内卵白蛋白激发8周,伴或不伴鼻内FP治疗。
  • 采用行为学测试、组织学分析、Western blotting及酶联免疫吸附试验检测嗅觉功能、OSN存在、神经元更新及鼻腔炎症。

主要发现

  • 正常小鼠鼻内FP治疗8周(FP-wk8)后嗅觉敏感度下降。
  • FP-wk8正常小鼠嗅觉敏感度下降伴随OSN及投射至嗅球的轴突丢失,主要源于神经元凋亡增加。
  • FP-wk8过敏性鼻炎小鼠鼻内FP治疗减轻嗅觉障碍及嗜酸性炎症,但未能重建OSN数量及轴突投射。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nasal eosinophilic inflammation is the therapeutic target for olfactory dysfunction in allergic rhinitis (AR). Intranasal corticosteroids are commonly considered to offer targetable benefit given their immunosuppressive property. However, experimental evidence suggests that continuous corticosteroid exposure may directly cause olfactory damage by disrupting the turnover of olfactory sensory neurons (OSNs). This potentially deleterious effect of corticosteroids calls into question their long-term topical use for treating olfactory loss related to AR. The aim of this study was to assess the impacts of chronic intranasal corticosteroid treatment on olfactory function and OSN population in mice under normal and pathological conditions. METHODS: BALB/c mice were intranasally treated with fluticasone propionate (FP, 0.3 mg/kg) for up to 8 weeks. Additional mice were used to establish an ovalbumin-induced mouse model of AR, followed by nasal challenge with ovalbumin for 8 weeks in the presence or absence of intranasal FP treatment. The authors examined olfactory function, OSN existence, neuronal turnover, and nasal inflammation using behavioral test, histological analyses, Western blotting, and enzyme-linked immunosorbent assay. RESULTS: Intranasal treatment with FP for 8 weeks (FP-wk8) reduced odor sensitivity in normal mice. This reduction was concomitant with loss of OSNs and the axons projecting to the olfactory bulb, primarily resulting from increased neuronal apoptosis. In FP-wk8 AR mice, intranasal FP treatment attenuated olfactory impairment and eosinophilic inflammation but failed to reconstitute OSN population and axonal projections. CONCLUSION: These results suggest that chronic intranasal corticosteroid treatment contributes to OSN degeneration that may reduce the therapeutic effectiveness for AR-related olfactory loss.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Li P, Wang N, Kai L, et al. Chronic intranasal corticosteroid treatment induces degeneration of olfactory sensory neurons in normal and allergic rhinitis mice. Int Forum Allergy Rhinol. 2023. PMID: 36800514. doi:10.1002/alr.23142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。